3B Blackbio Dx logo

3B Blackbio Dx Q1 results, quarter to Jun 2026

NSE: 3BBLACKBIOBSE: 532067Healthcare ServicesSmall Cap

3B Blackbio Dx Limited · Face value ₹10 · Listed Oct 1996
Last close ₹1,363.00down ₹18.60 (1.35%)BSE ₹1,362.55

Share price at the NSE close on 28 Oct 2026. Previous close ₹1,381.60.

28 Oct: open ₹1,378.00, high ₹1,398.10, low ₹1,354.90

52-week range of BSE trades to 28 Oct 2026
₹1,083.50Low, 2 Jun 2026₹1,750.00High, 19 Jan 2026
Market cap
₹1,170 Cr1,399th largest listed
P/E
21.07
P/B
3.61
Dividend yield
0.37%
ROE
18.7%
ROCE
14.1%
Debt to equity
0.01
Volume, NSE
4,67651.9% delivered

3B Blackbio Dx filed its Q1 results for the quarter to Jun 2026 on 13 Aug 2026 at 5:08 pm, consolidated: the company and its subsidiaries together.

Q1 results, quarter to Jun 2026

₹ crore.3B Blackbio Dx annual results and balance sheet

Revenue
₹33 Cr+50.6% on a year ago · −5.5% on the quarter before
Operating profit
₹8.52 Cr−28.0% on a year ago · +0.4% on the quarter before
Net profit
₹8.98 Cr−29.0% on a year ago · −8.4% on the quarter before
Earnings per share
₹10.48−29.0% on a year ago · −8.4% on the quarter before
Operating margin
25.4%
Net margin
26.8%

From revenue to net profit, ₹ crore

  1. Revenue33
  2. Materials and goods−7.6
  3. Employee costs−8.5
  4. Other expenses−8.9
  5. Operating profit8.5
  6. Depreciation−1.3
  7. Other income+6.1
  8. Finance costs−0.1
  9. Profit before tax13
  10. Tax−4.2
  11. Net profit9.0

3B Blackbio Dx results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
197.6Sep 23188.5Dec 23238.8Mar 241911Jun 242915Sep 242513Dec 24228.0Mar 252213Jun 253415Sep 255022Dec 25359.8Mar 26339.0Jun 26
Peak revenue ₹50 Cr, quarter to Dec 2025; lowest ₹18 Cr, quarter to Dec 2023

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
59.4%24.0%40.6%50.2%43.0%56.3%55.5%59.4%35.2%53.2%43.5%43.1%24.0%25.4%39.6%48.2%38.2%58.1%51.0%53.1%35.7%56.9%44.4%44.6%27.7%26.8%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Jun 26
₹ croreSep 2021Dec 2021Q3Mar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Filed 29 MayJun 2023Q1Filed 11 AugSep 2023Dec 2023Q3Mar 2024Jun 2024Q1Sep 2024Filed 13 NovDec 2024Q3Filed 13 FebMar 2025Q4Jun 2025Q1Filed 14 AugSep 2025Q2Dec 2025Q3Filed 6 FebMar 2026Q4Filed 29 MayJun 2026Q1Filed 13 Aug
Revenue from operations15.214.418.411.717.314.718.114.319.217.723.019.429.125.422.522.233.950.335.433.5
9.27.412.56.58.17.410.67.811.48.813.18.513.010.314.610.419.228.626.925.0
Materials and goods bought7.04.78.73.75.34.04.93.96.75.06.24.77.65.77.75.69.313.57.67.6
Employee costs0.81.00.91.01.11.41.51.41.91.61.61.62.11.71.91.84.68.29.48.5
Other expenses1.31.72.81.81.72.04.22.52.82.25.32.23.22.95.03.15.36.910.08.9
Operating profit before depreciation6.07.05.95.29.27.37.56.47.88.99.910.916.215.17.911.814.721.78.58.5
Operating margin39.5%48.6%32.1%44.3%53.1%49.7%41.2%45.1%40.6%50.2%43.0%56.3%55.5%59.4%35.2%53.2%43.5%43.1%24.0%25.4%
Depreciation and amortisation0.20.20.20.20.20.20.20.20.20.30.30.30.30.30.30.30.60.43.91.3
Other income1.91.51.91.22.02.91.23.02.72.64.23.73.43.04.94.35.55.610.16.1
Finance costs0.10.00.00.00.10.10.00.00.00.00.00.00.00.00.00.00.00.10.10.1
One-off items0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Profit before tax7.78.37.66.210.89.98.49.210.311.213.714.419.317.812.515.919.626.814.613.2
1.81.72.81.52.52.23.22.02.72.64.93.14.44.34.53.24.64.44.84.2
Tax rate23.6%21.0%36.8%24.2%23.3%22.1%37.9%21.6%26.0%23.6%36.0%21.3%23.0%24.2%35.9%20.3%23.4%16.4%33.1%32.1%
5.96.64.84.78.37.75.27.27.68.58.811.314.913.58.012.615.022.49.89.0
Net margin38.6%45.7%26.2%40.3%48.0%52.4%28.7%50.5%39.6%48.2%38.2%58.1%51.0%53.1%35.7%56.9%44.4%44.6%27.7%26.8%
Earnings per share₹6.84₹8.74₹6.43₹6.28₹11.07₹10.27₹6.92₹9.60₹8.86₹9.94₹10.26₹13.19₹17.35₹15.75₹9.38₹14.76₹17.55₹26.19₹11.44₹10.48
Earnings per share in rupees, restated for later splits and bonuses.

Segment results by quarter

Consolidated from the quarter to Dec 2023, standalone before, ₹ crore, quarters to Jun 2026.3B Blackbio Dx segment results by year

  • Diagnostic Kits

    Revenue, ₹ crore
    Profit, ₹ crore
  • Agrochemicals

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue of all businesses191823192925222234503533
Company revenue, as in its results191823192925222234503533
Revenue–1519172523192030493232
Revenue growth–23.9%31.1%40.9%–52.0%2.2%17.8%23.8%109.1%64.6%60.6%
Profit–1114141918131619271513
Profit growth–16.0%67.1%62.2%–54.0%−5.7%10.6%1.9%53.5%11.3%−16.3%
Margin–74.8%73.1%84.9%77.4%75.8%67.5%79.7%63.7%55.6%45.7%41.6%
Assets–213224238244257269268313384351359
Liabilities–111922141622934514453
Capital employed–203205216230242246259278333306306
Revenue524252323231
Revenue14–––––––––––
Profit is before tax and finance costs, the way companies report their segments.